Jan 15, 2026
Akeso is proud to announce that Professor Wang Ningli has been included as an effective candidate for the Medical and Health Division of the Chinese Academy of Engineering (CAE) Academician By-election.
The Chinese Academy of Engineering conducts its academicians by-election once every two years, making selection as an effective candidate a highly rigorous and competitive process.
For the 2025 by-election, a total of 660 effective candidates were confirmed across eight divisions and one special channel. Inclusion in this list reflects national-level recognition of sustained academic excellence, scientific contribution, and impact on industry and society.
According to the published list of effective candidates for the 2025 by-election, the Medical and Health Division ranked first in both number and proportion, with 91 candidates accounting for 13.79% of the total, tied with the Civil, Water Conservancy, and Architectural Engineering Division.
This highlights the growing strategic importance of medical science, healthcare innovation, and public health in China’s engineering and technological development.
Professor Wang Ningli is a member of the Chinese People’s Political Consultative Conference and Head of the National Technical Steering Group for Blindness Prevention. He serves as Dean of the School of Ophthalmology at Capital Medical University, is an Academician of the International Academy of Ophthalmology, President of the Ophthalmologists Branch of the Chinese Medical Doctor Association, and Editor-in-Chief of the Chinese Journal of Ophthalmology.
He is also a council member of the World Glaucoma Association and the Asia-Pacific Glaucoma Society. Over the past 35 years, Professor Wang has been deeply engaged in ophthalmic clinical practice and scientific research, has completed approximately 20,000 surgeries, and has served as an expert consultant for central government healthcare.
Through his long-term academic guidance and industry insight as the Chief Scientific Advisor, Professor Wang Ningli has supported Akeso’s continued focus on innovation in eye care technologies, myopia management solutions, and clinical research translation. His expertise has contributed to strengthening Akeso’s scientific foundation, clinical relevance, and alignment with evolving public health needs.
Akeso Eyecare is a doctor-founded eye-technology company and CDMO focused on improving vision care. We design and build advanced solutions like AR displays for myopia prevention, eye tracking, extended reality devices, and digital vision health tools used in eye care and smart technology.
Our mission is to improve global vision health through smart innovation. By combining optical design, materials science, and AI, our R&D team supports partners from early research to custom design, manufacturing, and large-scale production, always guided by medical expertise, collaboration, sustainability, and patient-first thinking.
Akeso – engineering the future of vision.